251 filings
Page 4 of 13
8-K
15uv6vtbeu5d
28 Jul 20
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:01pm
8-K
q82t9u8ry nu
19 May 20
Other Events
4:07pm
8-K
irfym1lxt6q2fl
14 May 20
Applied DNA Reports 2020 Fiscal Second Quarter Financial Results
4:05pm
8-K
49ucmox8 1u
5 May 20
Regulation FD Disclosure
9:00am
8-K
3dwc94x70ya0f
6 Feb 20
Applied DNA Reports 2020 Fiscal First Quarter Financial Results
4:05pm
8-K
so2u6v8u
12 Dec 19
Applied DNA Reports 2019 Year End and Fiscal Fourth Quarter Financial Results
4:05pm
8-K
tv0pb4s30 4csvedplt
6 Dec 19
Termination of a Material Definitive Agreement
9:00am
8-K
ccin0a1nxedw3os
26 Nov 19
Sent via electronic delivery
4:16pm
8-K
n0g1sl4p 25498j612
18 Nov 19
Applied DNA Sciences Announces Closing of
9:01am
8-K
szama
13 Nov 19
Applied DNA Sciences Announces Pricing of Upsized $12.0 Million Underwritten Public Offering
9:49pm
8-K
eh85yh6jt18o2j9
8 Nov 19
Applied DNA Sciences Announces Appointment of Scott L. Anchin to Board of Directors
4:16pm
8-K
9skdyipg
31 Oct 19
Applied DNA Sciences Announces 1-for-40 Reverse Stock Split
4:06pm
8-K/A
nzoklb1mnhuxjeqnffrc
3 Oct 19
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
by3et8v3 lu
3 Oct 19
Applied DNA Receives Extension from Nasdaq
6:31am
8-K
nycuamvh
26 Aug 19
Entry into a Material Definitive Agreement
4:05pm
8-K
2xt 7it7i4gwyd
13 Aug 19
Applied DNA Reports Fiscal Third Quarter 2019 Financial Results
4:06pm
8-K
msbm2m20g545pt6n
12 Aug 19
LineaRx Acquires Assets and Intellectual Property of Vitatex
4:17pm
8-K
fpx0abnpxm7i qr6
2 Aug 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
lbhb9l 88ds0mi
17 Jul 19
Entry into a Material Definitive Agreement
5:08pm
8-K
p3vg 5dayvz0h
20 May 19
Submission of Matters to a Vote of Security Holders
4:06pm